We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

September 22, 2017

AMGEN INC et al v. MYLAN INC. et al

Track this case

Case Number:



Pennsylvania Western

Nature of Suit:



Mark R. Hornak



Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. April 9, 2018

    Amgen's Patent Not Used In Neulasta Biosimilar, Mylan Says

    Mylan Inc.’s proposed Neulasta biosimilar doesn’t use the salt pairs covered in a patent Amgen Inc. is accusing it of infringing, Mylan told a Pennsylvania federal court Friday, hoping to get the claim killed by relying on an argument that got a similar suit over the patent dismissed last month.

1 other articles on this case. View all »


To view the parties, register now.